INTRODUCTION
============

Thyroid nodules are common in clinical practice. They are found in 4--8% of the general population via palpation, in 19--67% of patients via ultrasound (US), and in 50% of autopsy specimens ([@B1][@B2][@B3][@B4][@B5][@B6]). Malignancies occur in 5--15% of thyroid nodules ([@B3][@B7][@B8]), and the incidence of thyroid cancer continues to increase worldwide due to various factors including genetic and environmental factors, development of medical devices, and the widespread implementation of healthcare programs. In Korea, thyroid cancer was the most common cancer in adults in 2013, being the most prevalent cancer in females and sixth most prevalent in males ([@B9]).

Various imaging techniques and procedures have been developed for the differential diagnosis of thyroid nodules. Imaging techniques include US, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). Procedures including palpation-guided fine-needle aspiration (FNA), US-guided FNA, and US-guided core needle biopsy (CNB) allow confirmation of nodules ([@B10][@B11]). The need for standardized evidence-based clinical guidelines for the management of thyroid nodules has been proposed, and the Korean Society of Radiology (KSR) and the National Evidence-based Healthcare Collaborating Agency (NECA) organized a development committee and working group to develop such guidelines ([@B12]).

Development of Korean Clinical Imaging Guidelines for Thyroid Nodules
=====================================================================

Committee Composition
---------------------

The guideline development process involved collaboration between NECA and KSR. NECA is a national agency that provides evidence-based information about medical devices, medicines, and health technology obtained through objective and reliable analyses. The development committee included medical imaging experts, research methodology specialists, and clinical guideline specialists who support the overall planning and research methodology. They published a methodology for the guideline adaptation process in imaging diagnosis ([@B12]). The working group included expert members of the Korean Society of Thyroid Radiology (KSThR). KSThR is an organization composed of thyroid radiologists in Korea that is primarily involved in the diagnosis and nonsurgical treatment of thyroid nodules. KSThR has published several sets of guidelines for thyroid imaging ([@B11][@B13]), biopsy ([@B10][@B14]), and radiofrequency ablation ([@B15]). The working group participated in the guideline development process and wrote recommendations ([@B12]).

Adaptation Process of the Guideline
-----------------------------------

The guideline development process employed an adaptation methodology for Korean clinical imaging guidelines (K-CIG) established by the development committee ([@B12]).

### Defining Key Questions

The Key Questions selected by the working group were reviewed by the development committee and a consensus group composed of clinical experts. Two final Key Questions were identified:

1\) What is the primary imaging test for diagnosis in patients with suspected thyroid nodules?

2\) What is the appropriate biopsy method for thyroid nodules?

### Search for Guidelines

A systematic search for guidelines was performed using international databases published up to July 2015, including Ovid-MEDLINE, Ovid-EMBASE, National Guideline Clearinghouse, Guideline International Network, and major domestic databases including KoreaMed, KMBASE, Korean Medical Guidelines and Information, and Korean Guideline Clearinghouse. The websites of major academic societies and institutions were also searched.

### Selection of Searched Guidelines

A total of 352 and 207 studies addressed Key Questions 1 and 2, respectively. Guideline selection was performed independently based on predefined inclusion/exclusion criteria. After excluding duplicates, screening titles and abstracts, and reading the full texts of the remaining articles, 9 and 5 articles, respectively, were selected ([Figs. 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}).

### Quality Appraisal of the Guidelines

The selected guidelines underwent a quality appraisal process using the Korean Appraisal of Guidelines for Research and Evaluation II tool developed by the guideline development committee. Guidelines with a score of less than 50 in the "Rigour of Development" domain were not recommended by the development committee. An exception was the "ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations" ([@B13]), which was selected despite its low score because it was established by domestic thyroid-imaging experts. After this process, five guidelines each were selected for Key Questions 1 and 2 ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}).

### Grading the Level of Evidence and Drafting the Recommendation Document

The working group members reviewed evidence literatures that supported the recommendations of the selected guidelines. Grading the level of evidence of each literatures was performed according to the evidence level criteria of the K-CIG ([@B12]). After discussion and comparison of recommendations and their evidence literatures of selected guidelines, draft recommendations were prepared by the working group.

### Agreement of the Recommendation Grades

The draft written by working group was reviewed and discussed by the development committee. Then, together, both groups came to a consensus on the recommendations grade and the evidence level, according to the criteria of the K-CIG ([@B12]).

### Finalizing the Recommendation Document

The Delphi method was used for formal consensus. The consensus group was composed of clinical imaging experts, clinical imaging guidelines-related academic societies (end-users), and research methodology experts. The agreement level for each recommendation, the grade of each recommendation, and the evidence level were rated from strongly disagree (level 1) to strongly agree (level 9). After two rounds of assessment, a consensus was reached. The average degree of agreement was 7.80 (standard deviation: 1.25) for recommendation 1 and 7.60 (standard deviation: 1.19) for recommendation 2.

### External Review and Approval of Clinical Guidelines

Final recommendations were reviewed by clinical experts of a related medical society, the Korean Thyroid Association, and appropriate modifications were made.

Recommendations
---------------

### Key Question 1) What Is the Primary Imaging Test for Diagnosis in Patients with Suspected Thyroid Nodules?

#### \[Recommendation 1\]

We recommend neck US for the diagnosis of thyroid nodules detected by imaging other than US or in patients with suspected thyroid nodules.

(recommendation grade A, evidence level II)

Evidence Summary
----------------

After reviewing the guidelines for diagnosis and treatment of thyroid nodules, final five guidelines were selected ([@B13][@B16][@B17][@B18][@B19]). In all five guidelines, neck US is recommended for diagnosis when a thyroid nodule is suspected. US is a highly sensitive diagnostic method for thyroid nodules and can be used to diagnose nodules and determine the need for FNA tests.

According to US and the US-based management of thyroid nodules: consensus statement and recommendations, high-resolution neck US is the most sensitive method for detecting thyroid nodules, and a neck US examination is recommended for diagnosis of suspected thyroid nodules ([@B13]). US is used to determine the size and morphologic features of the nodule, diagnose nodal involvement, and determine the need and possibility of US-guided FNA.

According to the American Thyroid Association (ATA) Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer, US of the thyroid gland and cervical lymph nodes is recommended in patients with suspected thyroid nodule or with incidental thyroid nodules detected via CT, MRI, or PET, for the diagnosis of thyroid nodule ([@B17]). It is recommended to confirm via neck US whether the lesion causing the symptom is related to the thyroid nodule; analyze the location, size, and morphological characteristics of the nodule; and ascertain whether neck lymph node metastasis has occurred ([@B20][@B21][@B22]).

The British Thyroid Association (BTA) Guidelines for the Management of Thyroid Cancer define neck US as a sensitive technique for the diagnosis of thyroid nodules and recommend neck US for differential diagnosis of papillary thyroid cancer ([@B18]). US is useful for determining the US-guided FNA test according to the morphologic findings of the nodule and for increasing the diagnosis rate ([@B23][@B24]).

According to the American Association of Clinical Endocrinologists (AACE), Associazione Medici Endocrinologi (AME), and European Thyroid Association (ETA) Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules, neck US is the most useful test for the detection and diagnosis of thyroid nodule, and for the determining changes in the thyroid parenchyma ([@B16]). These guidelines recommend US if a nodule needs to be touched or if there is suspicion of thyroidopathy ([@B25]), as well as to confirm thyroid pathology in the presence of palpable neck lymph nodes, because cervical lymph node metastasis due to asymptomatic thyroid cancer cannot be excluded.

The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for thyroid carcinoma (ver. 2) recommend neck US as a primary diagnostic test in patients with suspected thyroid nodules ([@B19]). US-guided FNA or US follow-up should be performed based on the comprehensive result of US finding of the initial scans, together with clinical findings, thyroid-stimulating hormone levels, and thyroglobulin levels.

Considerations for Recommendations
==================================

Harms and Benefits
------------------

Ultrasound is a very sensitive method for the detection and diagnosis of thyroid nodules. There is no risk of radiation exposure, and it is also possible to evaluate changes in the thyroid parenchyma and to examine lymph node status. US can also be used to determine the need for US-guided FNA, and improves the accuracy of diagnosis ([@B23][@B24]).

However, thyroid nodules are very common and often asymptomatic. No US features that are specific to malignant thyroid nodules have been identified ([@B7]). Furthermore, several US findings are evident in both benign and malignant thyroid nodules ([@B20][@B24][@B26]). This may lead to unnecessary FNA of benign nodules, which may lead to increased medical expenditures and unnecessary complications. However, the cost-effective aspect of the increase in medical expenditures may vary depending on whether or not medical insurance is applied. Finally, the US diagnosis of nodules can cause unnecessary worry and anxiety in patient.

Acceptability and Applicability
-------------------------------

Neck US was chosen as the primary imaging method for patients with suspected or diagnosed thyroid nodule in five medical guidelines. As a result of the evaluation of domestic acceptability and applicability of these five guidelines, it was concluded that the applicability of neck US to the detection and diagnosis of thyroid nodules was reasonable.

Radiation Dose
--------------

Neck US: 0

### Key Question 2) What Is the Appropriate Biopsy Method for Thyroid Nodules?

#### \[Recommendation 2\]

Ultrasound-guided FNA is recommended for histologic examination of thyroid nodules.

(recommendation A, evidence level II)

Evidence Summary
----------------

The five final guidelines were selected for appropriate testing methods for histologic diagnosis of thyroid nodules ([@B13][@B16][@B17][@B18][@B19]). All five guidelines recommend FNA for histologic examination of thyroid nodules. Moreover, according to several comparisons between palpation-guided FNA and US-guided FNA ([@B23][@B27][@B28][@B29]), the latter is better in terms of non-diagnostic results, specimen errors, and false-negative results.

The BTA Guidelines for the management of thyroid cancer published in 2014 state that FNA is a valuable, cost-effective preoperative test and that US-guided FNA improves the accuracy of diagnosis and reduces the probability of obtaining an inappropriate sample ([@B18]). In a prospective study of 215 patients, the non-diagnostic result rate (21.4%) of the US-guided FNA was significantly lower than that of palpation-guided FNA (32.4%), and the false negative result of US-guided FNA (5.6%) was also significantly lower than that of palpation-guided FNA (15.8%) ([@B23]).

The ATA Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer strongly recommend FNA as the most accurate and cost-effective test for evaluating thyroid nodules ([@B17]). In a retrospective study, US-guided FNA had a significantly low non-diagnostic rate (3.5%) and false-negative rate (1%), compared to palpation-guided FNA (8.7% and 2.3%, respectively) ([@B30]). Particularly in cases of cystic, untouchable, or deep-located nodules, US-guided FNA is recommended because of the high probability of non-diagnostic result and sample errors. However, if the nodules are palpable and have a solid component, both US-guided FNA and palpation-guided FNA can be used. The diagnostic sensitivity, specificity, and accuracy of US-guided FNA were 97.1%, 100%, and 75.9%, respectively ([@B29][@B30]).

The ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations ([@B13]) recommend performing US-guided FNA for histological diagnosis but do not cite any specific evidence.

The AACE/AME/ETA Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules published in 2010 recommend that the diagnosis of thyroid nodules should be based on the results of US and FNA, and that FNA should be done under US guidance to increase reliability and reduce the non-diagnostic result rate ([@B16]). US-guided FNA is strongly recommended when nodules are not palpable or are multinodular, when patients are obese, and/or when cervical muscles are highly developed ([@B27][@B28][@B30][@B31][@B32][@B33]). In one prospective study of 386 patients, US-guided FNA showed significantly lower non-diagnostic rate (12.5%) than that of palpation-guided FNA (27.2%) ([@B27]).

The NCCN Clinical Practice Guidelines for thyroid carcinoma (ver. 2) recommend that FNA should be performed for histologic diagnosis if the US findings meet the indication ([@B19]), particularly when unsuitable specimens or non-diagnostic results are obtained from previous FNAs conducted on solid nodules. However, they cite no specific evidence.

Considerations for Recommendations
==================================

Harms and Benefits
------------------

Ultrasound-guided FNA of thyroid nodules is a relatively easy and safe procedure, and is more accurate and less complicated than palpation-guided FNA ([@B23][@B27][@B28][@B29]). Therefore, it can be performed by any doctor who specializes in thyroid.

However, the rate of non-diagnostic results depends on various factors such as technical proficiency of the practitioner, processing errors, and internal factors of the nodule itself. Therefore, efforts should be made to minimize non-diagnostic results ([@B13]). Recent reports have indicated that US-guided CNB may be an alternative to FNA in the case of nodules with non-diagnostic results in previous US-guided FNA ([@B34][@B35]). The reported complication rate of US-guided FNA were 0--8.6%, and most complications were hematoma around the thyroid gland, edema of the thyroid gland, and temporary changes in the voice. Severe complications requiring hospitalization were rare. Practitioners should be familiar with the appropriate preparation, prevention, and treatment methods to avoid complications in patients with a bleeding tendency. Unnecessary US-guided FNA for benign nodules can increase patient anxiety, and lead to unnecessary medical expenditures.

Acceptability and Applicability
-------------------------------

Ultrasound-guided FNA was recommended as an appropriate histologic examination of thyroid nodules in all five medical guidelines. It was concluded that the domestic acceptability and applicability of the five guidelines were acceptable.

Radiation Dose
--------------

Neck US: 0

SUMMARY
=======

These are the first evidence-based clinical imaging guidelines for thyroid imaging in Korea, and was developed using an adaptation process. The guidelines recommend that neck US as the first-line imaging modality for diagnosing thyroid nodules detected by imaging modalities other than US or in patients with suspected thyroid nodules, and US-guided FNA for primary histologic examination of thyroid nodules. We expect that these recommendations will be helpful in the clinical practice in the management of thyroid nodules.
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###### Recommendation Matrix of Existing Guidelines (Key Question 1)

![](kjr-19-623-i001)

  Source Guidelines (Publication Year)                                                                                                                 AGREE II (Domain 3. Rigour of Development)   Recommendation                                                                                                                                                                                                     Grading of Recommendation
  ---------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------
  2015 ATA Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer (2016)                                      63                                           Thyroid sonography with survey of cervical lymph nodes should be performed in all patients with known or suspected thyroid nodules (strong recommendation, high-quality evidence)                                  Strong recommendation, high-quality evidence
  Thyroid carcinoma, version 2. 2015 (NCCN Guideline) (2015)                                                                                           74                                           For thyroid nodules known or suspected on clinical or imaging findings, US recommended (category 2A)                                                                                                               Category 2A
  BTA Guidelines for management of thyroid cancer (2014)                                                                                               84                                           US is extremely sensitive examination for thyroid nodules. It can be specific for diagnosis of thyroid carcinoma (particularly papillary carcinoma), and aids decision making about which nodules to perform FNA   Good practice point
  i\. All patients being investigated for possible thyroid cancer should undergo US of neck in secondary care by appropriate, competent practitioner                                                                                                                                                                                                                                                                   
  Ultrasonography and ultrasound-based management of thyroid nodules: consensus statement and recommendations (2011)                                   41                                           Among modern imaging modalities, high-resolution US is most sensitive diagnostic modality for detection of thyroid nodules and it is necessary to perform US for nodules found after palpation.                    Not available
  AACE/AME/ETA Medical Guidelines for clinical practice for diagnosis and management of thyroid nodules (2010)                                         69                                           US evaluation is recommended for (grade B; BEL 3):                                                                                                                                                                 Grade B; BEL 3
  \- Patients at risk for thyroid malignancy                                                                                                                                                                                                                                                                                                                                                                           
  \- Patients with palpable thyroid nodules or MNGs                                                                                                                                                                                                                                                                                                                                                                    
  \- Patients with lymphadenopathy suggestive of malignant lesion                                                                                                                                                                                                                                                                                                                                                      

AACE = American Association of Clinical Endocrinologists, AGREE = Appraisal of Guidelines for Research & Evaluation, AME = Associazione Medici Endocrinologi, ATA = American Thyroid Association, BEL = best evidence level, BTA = British Thyroid Association, ETA = European Thyroid Association, FNA = fine-needle aspiration, MNG = multinodular goiter, NCCN = National Comprehensive Cancer Network, US = ultrasound

###### Recommendation Matrix of Existing Guidelines (Key Question 2)

![](kjr-19-623-i002)

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source Guidelines (Publication Year)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             AGREE II (Domain 3. Rigour of Development)   Recommendation                                                                                                                                                                                                                                                                     Grading of Recommendation
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------
  2015 ATA Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer (2016)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  63                                           \(a\) FNA is procedure of choice in evaluation of thyroid nodules, when clinically indicated (strong recommendation, high-quality evidence)                                                                                                                                        Strong recommendation, high-quality evidence

  Thyroid carcinoma, version 2. 2015 (NCCN Guideline) (2015)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       74                                           THYR-1: consider FNA based on clinical and sonographic features                                                                                                                                                                                                                    Category 2A

  BTA Guidelines for management of thyroid cancer (2014)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           84                                           i\. US appearances that are indicative of benign nodule (U1-2) should be regarded as reassuring not requiring FNA cytology, unless patient has statistically high risk of malignancy (chapter 3.7) (2++, B)                                                                        (2++, B)

  ii\. If US appearances are equivocal, indeterminate or suspicious of malignancy (U3-5), US guided FNA should follow (2++, B)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Ultrasonography and ultrasoundbased management of thyroid nodules: consensus statement and recommendations (2011)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                41                                           We recommend performing FNA for nodule of any size that has suspicious malignant findings if FNA is feasible and nodule is larger than 5 mm in size. For nodule smaller than 5 mm, selective FNA can be done according to patient's risk factors and experience of radiologists.   Not available

  If nodule has indeterminate findings on US and it is larger than 1 cm in diameter, then performing FNA is recommended due to fact that possibility of malignancy cannot be excluded. If nodule has indeterminate findings and it is 1 cm or less in size, then FNA biopsy is not necessary and followup US would suffice. If benign appearing nodule is larger than 1 cm, then we recommend performing follow-up US in two years and thereafter at 3--5 year intervals. If benign appearing nodule (i.e., spongiform nodule) is larger than 2 cm, then selective FNA biopsy can be done. Neither FNA nor follow up US is necessary for spongiform nodule and benign appearing nodule 1 cm or less in diameter.                                                                                                                                                                                                                                                                                                                                   

  AACE/AME/ETA Medical Guidelines for clinical practice for diagnosis and management of thyroid nodules (2010)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     69                                           3.7.2.1. How to select nodule(s) for FNA biopsy (grade B; BEL 3):                                                                                                                                                                                                                  3.7.2.1. grade B; BEL 3\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   3.7.2.2. grade D, grade B; BEL 4

   1) FNA biopsy is recommended for nodule(s):                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   - Of diameter larger than 1 cm that is solid and hypoechoic on US                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

   - Of any size with US findings suggestive of extracapsular growth or metastatic cervical lymph nodes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

   - Of any size with patient history of neck irradiation in childhood or adolescence; PTC, MTC, or MEN 2 in first-degree relatives; previous thyroid surgery for cancer; increased calcitonin levels in absence of interfering factors                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

   - Of diameter smaller than 10 mm along with US findings associated with malignancy (see section 3.7.1.2.); coexistence of 2 or more suspicious US criteria greatly increases risk of thyroid cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

   2) Nodules that are hot on scintigraphy should be excluded from FNA biopsy (see difference in recommendations for children; section 8.4.)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  3.7.2.2. FNA biopsy of multinodular glands                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

   1) It is rarely necessary to biopsy more than 2 nodules when they are selected on basis of previously described criteria (grade D)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

   2) If radioisotope scan is available, do not biopsy hot areas (grade B; BEL 4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MEN = multiple endocrine neoplasia, MTC = medullary thyroid cancer, PTC = papillary thyroid cancer
